GlaxoSmithKline Takes Over Entirety of Cambridge Building

British pharmaceutical giant GlaxoSmithKline is growing its Cambridge, MA footprint and workforce, taking over the entirety of King Street Properties’ 222,000-square-foot 200 CambridgePark Dr. in Cambridge, a six-story building that will eventually house about 400 workers. The Boston Business Journal reported that the expansion comes after GSK announced earlier this year that it will move its vaccine R&D and infectious disease teams to Cambridge from Maryland.

Chris Austin, SVP of research technologies at GSK, told the Business Journal that filling up 200 CambridgePark will require a combination of bringing in workers from Maryland and hiring locally in Massachusetts. He said GSK first came to the Boston area about a decade ago to take advantage of its talent.

“Cambridge and Boston in general, in my view, is still untouchable there, and it’s one of the reasons why we located here and will continue to expand here,” Austin said. GSK has two other Cambridge facilities; it’s not clear what GSK plans to do with those spaces.

The post GlaxoSmithKline Takes Over Entirety of Cambridge Building appeared first on Connect CRE.